Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of Lemborexant for the Prevention of Delirium After Cardiac Surgery (PROTEX): A Pilot Study

NCT06648681 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT06648681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06648681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of Lemborexant for the Prevention of Delirium After Cardiac Surgery (PROTEX): A Pilot Study
Lead sponsor
University of British Columbia
Phase
Phase 2
Overall status
Not yet recruiting
Start date
May 1, 2025
Completion date
April 30, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery, cardiac surgery subjects, delirium - postoperative, feasibility studies, in-hospital mortality, orexin antagonist, sleep